Bayer Pakistan’s Pharmaceutical Division has announced the commercial launch of a new medication for the treatment of endometriosis, further strengthening its women’s healthcare portfolio.

Endometriosis is a painful inflammatory condition that affects women of reproductive age, most commonly between 20 and 45 years. It occurs when tissue similar to the uterine lining grows outside the uterus, leading to inflammation and the formation of scar tissue. The condition can cause chronic pelvic pain, heavy bleeding during or between periods and fertility challenges.

In Pakistan, the prevalence of endometriosis is rising, with an estimated 2.2 million women living with the condition. Despite its frequency, diagnosis takes an average of six to seven years, resulting in prolonged and often unnecessary suffering for many patients.

Speaking at the launch, Khurram Mirza, the country head for Bayer Pakistan’s Pharmaceutical Division, said the introduction of the new therapy marked an important step for women’s health in the country. “We are pleased to bring a new treatment option for women suffering from endometriosis. The condition significantly affects quality of life and well-being. It also impacts productivity and places an economic burden on healthcare systems, all of which require urgent and sustainable solutions,” he said.

He added that the launch reflected Bayer’s broader mission. “Our teams have worked diligently to make this possible, and this milestone demonstrates our commitment to Bayer’s global purpose of Health for All, Hunger for None, particularly in the area of women’s health.”

Bayer is recognised globally as a leader in women’s health and has committed to providing 100 million women in low and middle income countries with access to family planning by 2030.

In Pakistan, the company offers a broad range of contraceptive options and therapies addressing multiple aspects of women’s reproductive health. Bayer Pakistan continues to focus on expanding access to innovative treatments to improve patient outcomes and contribute to the overall health of the population.

This content is an advertorial by Bayer Pakistan and is not associated with or necessarily reflective of the views of Dawn.com or its editorial staff.